
PRBCF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for PRBCF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for PRBCF and 80,000+ other tickers.
See exactly how PRBCF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PRBCF and 80,000+ other tickers.
Precise Biometrics AB (publ) develops specialized software for reliably confirming individuals' identities across Europe, Asia, and the United States. Its product lineup includes Precise YOUNiQ, designed for digital identity verification; the BioMatch series, which comprises fingerprint algorithm solutions like BioMatch Card for secure authentication on smart cards and BioMatch Mobile for integration into smartphones and tablets; and Precise BioLive, a fingerprint software capable of detecting fake or spoofed fingerprints. The company's offerings are utilized by a wide range of clients…

Precise Biometrics AB (publ) (PRBCF) Discusses Merger Strategy With Fingerprint Cards and Use of Rights Issue Proceeds Transcript

Precise Biometrics AB (publ) (PRBCF) M&A Call Transcript

Biometric stocks were already relevant before the pandemic, but they will be even more so as we eventually return to normal. The post 8 Biometric Stocks to Consider as We Eye a Return to Normal appeared first on InvestorPlace.